Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The digital approach allows companies to organize and take a more data-driven strategy when compiling submissions.
March 7, 2023
By: Jason Berning
Associate Director Business Development for Quality Compliance Solutions at IQVIA
Regulatory submission and filing requirements have become more complex than ever before, and they’re not slowing down as technology opens doors to new methods and greater volumes of data for regulators to consider. In fact, we’re seeing regulatory agencies require much more information. Forty years ago, documentation that needed to be submitted may have averaged 50 pages, while today it could be thousands. Zooming in even further, the regional regulatory requirements that life sciences companies are subject to, depending on where they wish to market their products, become vaster and more difficult to manage the more global the company’s scale. It’s not an issue that can be solved with more new hires alone – particularly not in the midst of the multi-year talent shortage crisis that the industry currently faces. Rather, automation technologies can assist with these filing and publishing processes, allowing teams to focus on more strategic initiatives. But when the adoption of this information is forced, can it truly be embraced across the industry? Digital regulatory information frameworks must be adopted to optimize the submission process and ensure consistency of information. Technologies and data use only enhance regulatory filings as greater amounts of data and more complex information can be easily assessed. Gearing Up for Change As life sciences companies pursue digitally transformed regulatory publishing and information practices, the biggest constraints they face is time and the volume of data to process. Time is money, and every day that they can shorten a review process could equate to millions in revenue, improved relationships with the local regulators, and invaluable brand recognition by patients and providers. Technology service partners can and should help bridge the gaps to advance digital transformation without taking the company’s focus off regulatory adherence. When evaluating the short- and long-term value of a partner to support the transition to digital processes, there are critical questions that companies should be asking, such as:
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !